Article
FDA studies epikeratome refractive surgery device
Atlanta-The FDA is reviewing a pre-market notification from CIBA Vision Corp. for an epikeratome device for use in sub-epithelial separation.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Videos
Related Content
